Hydrokortison Orion

Hydrocortisone, the active ingredient in Hydrokortison Orion, is a corticosteroid presented as an oral formulation for systemic use and is approved in the European Union. It is employed to replace deficient cortisol in adrenal insufficiency, to reduce inflammation in various disorders, and to mitigate severe allergic reactions.

GNH USA supplies Hydrokortison Orion as a licensed, GDP‑compliant international pharmaceutical product to hospitals, pharmacies and clinics worldwide, supporting global procurement needs. The company adheres to stringent quality standards and provides regulatory documentation for each batch.

Hydrocortisone acts as a glucocorticoid to modulate inflammatory and immune pathways in several clinical conditions. - Adrenal insufficiency: restores cortisol levels to maintain metabolic homeostasis. - Inflammatory disorders: reduces swelling, pain and tissue damage associated with conditions such as rheumatoid arthritis or ulcerative colitis. - Allergic reactions: suppresses hypersensitivity responses in severe allergy or anaphylaxis.

Hydrocortisone may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Increased appetite. - Weight gain. - Insomnia. - Mood swings. - Mild hyperglycemia. - Gastrointestinal discomfort.

Serious or Rare Side Effects: - Adrenal crisis on abrupt withdrawal. - Severe infection risk. - Osteoporosis. - Cataracts. - Severe hypertension. - Psychosis.

Before prescribing Hydrokortison Orion, clinicians should consider several safety measures. - Assess adrenal function before initiating: confirm diagnosis and baseline cortisol levels. - Monitor blood glucose regularly: detect hyperglycemia early. - Use lowest effective dose: minimize systemic exposure. - Avoid abrupt discontinuation: taper gradually under medical supervision. - Store at room temperature: keep in original container, protect from moisture and light.

Hydrocortisone can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may increase hydrocortisone levels leading to toxicity. - Anticoagulants (warfarin): enhanced anticoagulant effect, risk of bleeding. - Live vaccines: immunosuppression may reduce vaccine efficacy.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): increased risk of gastrointestinal ulceration. - Diabetic medications (insulin, oral hypoglycemics): may require dose adjustment due to altered glucose metabolism. - Inactivated vaccines: monitor immune response.